Breaking News

Aptar CSP Launches cGMP-Compliant Manufacturing Facility in NJ

The new site will support clinical packaging for oral solid dose (OSD) and capsule-based DPI drugs.

Author Image

By: Charlie Sternberg

Associate Editor

Aptar CSP Technologies, part of AptarGroup Inc., has expanded its service offerings with the launch of a cGMP-compliant manufacturing facility in New Jersey. The new site will support clinical packaging for oral solid dose (OSD) and capsule-based DPI drugs utilizing Aptar CSP’s proprietary Activ-Polymer platform and Activ-Blister solutions. The expansion addresses growing market demand for enhanced drug stability and nitrosamine risk mitigation. Aptar CSP’s Activ-Blister technology integrates...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters